Who are Daré Bioscience, Inc.'s main suppliers?

Daré Bioscience, Inc. (DARE) key suppliers include: SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/DARE.

Who are Daré Bioscience, Inc.'s major customers?

Daré Bioscience, Inc. (DARE) key customers include: GATES-FOUNDATION, ORANY, ORANY. View the full customer network at chainsifter.com/chain/DARE.

What sector is Daré Bioscience, Inc. in?

Daré Bioscience, Inc. (DARE) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

DARE Supply Chain: Daré Bioscience, Inc. Supplier List & 9 Relationships

3Suppliers

3Customers

3Debt Items

20Related Chains

Daré Bioscience, Inc. Suppliers

Ticker	Name	Confidence	Evidence
SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES	SECTION-503B-REGISTERED-OUTSOURCING-FACILITIES	90%	the Company makes unsecured advances to certain suppliers, specifically, the Section 503B-registered outsourcing facilities engaged to manufacture and distribute the Company's Section 503B products
ORANY	ORANY	72%	her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found.…

Daré Bioscience, Inc. Customers

Ticker	Name	Confidence	Evidence
GATES-FOUNDATION	GATES-FOUNDATION	92%	The Foundation Services Agreements are accounted for as contracts with a customer under FASB Accounting Standards Codification (ASC) 606, as each represents an exchange transaction in which the Found…
ORANY	ORANY	72%	her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA within ten working days after the recall is initiated. As with prescription drugs, th…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DARE graph: her material deficiency is found. The FDA requires that certain classifications of recalls be reported to the FDA wi…

Daré Bioscience, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DARE-DEBT	Debt stack $1.6M	90%	Market cache reports total debt of $1.6M.
DARE-DEBT-9018	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-12-31.
DARE-DEBT-9017	Warrants outstanding: 265485	90%	xbrl warrant detail from xbrl 2023-12-31.

Daré Bioscience, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Daré Bioscience, Inc..

Daré Bioscience, Inc. Ownership

Holder	Name	Confidence	Evidence
DARE-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 26 tracked holders.

Daré Bioscience, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
SCNX	Scienture Holdings, Inc.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
BSBK	Bogota Financial Corp.	50.00	2
BLTE	Belite Bio, Inc	50.00	2

Daré Bioscience, Inc. Supply Chain